Sinovac vaccine effective but some data lacking - WHO experts

ReutersPublished: May 6, 2021 1:45 AM

The Covid-19 vaccine produced by China's Sinovac Biotech is efficacious in preventing Covid-19 in adults under 60, but some quality data on the risk of serious adverse effects is lacking, World Health Organization experts have found.

The independent experts on the WHO's Strategic Advisory Group of Experts (Sage) reviewed Sinovac's CoronaVac jab from phase 3 clinical trials in China, Brazil, Indonesia, Turkey and Chile.

Almost 20pct of Kelantan seniors didn't turn up for vaccine appointment

EU regulator begins real-time review of first Sinovac Covid-19 vaccine

YOURSAY | ‘Priority should be given to senior citizens in AstraZeneca rollout’

KJ: Pahang decided hotel sector vaccination before JKJAV changed Sinovac advisory

All AstraZeneca Covid-19 doses snapped up in less than 4 hours

AstraZeneca round 2: How to sign up and what to know?

Comments0

By posting a comment, you agree to our Commenting Terms and Conditions as stipulated in full here.

Do's and don'ts when posting comments in Malaysiakini

TERMS & CONDITIONS

Foul language, profanity, vulgarity, slanderous, personal attack, threatening, sexually-orientated comments or the use of any method of communication that may violate any law or create needless unpleasantness will not be tolerated. Antisocial behaviour such as "spamming" and "trolling" will be suspended. Violators run the risk of also being blocked permanently.

REPORT VIOLATORS

Please use the report feature that is available below each comment to flag offending comments for our moderators to take action. Do not take matters in your own hands to avoid unpleasant and unnecessary exchanges that may result in your own suspension or ban.

NOTICE

Our commenting system is still under development. We have taken note of feedback provided.

Subscriber-only space: